Amgen
AMGN
1,881 hedge funds and large institutions have $91B invested in Amgen in 2019 Q1 according to their latest regulatory filings, with 93 funds opening new positions, 721 increasing their positions, 807 reducing their positions, and 112 closing their positions.
0.07% more ownership
Funds ownership: 76.95% → 77.02% (+0.07%)
0% less funds holding
Funds holding: 1,888 → 1,881 (-7)
11% less repeat investments, than reductions
Existing positions increased: 721 | Existing positions reduced: 807
17% less first-time investments, than exits
New positions opened: 93 | Existing positions closed: 112
47% less funds holding in top 10
Funds holding in top 10: 133 → 71 (-62)
50% less call options, than puts
Call options by funds: $783M | Put options by funds: $1.58B
51% less capital inflows, than outflows
Capital inflows: $2.91B | Capital outflows: $5.96B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$268M |
| 2 |
D.E. Shaw & Co
New York
|
+$212M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$153M |
| 4 |
Legal & General Group
London,
United Kingdom
|
+$138M |
| 5 |
State Street
Boston,
Massachusetts
|
+$128M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.48B |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$334M |
| 3 |
Capital International Investors
Los Angeles,
California
|
-$314M |
| 4 |
Morgan Stanley
New York
|
-$241M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$197M |
AMGN Hedge Fund Activity: Q1 2019 in Review
1,881 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2019, worth a combined $91B — down 4.6% from $95.4B a quarter earlier.
Sellers outnumbered buyers: 112 funds closed out of AMGN and 93 opened new positions — a net loss of 19 holders — while 807 trimmed existing stakes and 721 added.
The largest buyer was Wells Fargo, adding an estimated $268M. The largest seller was Fidelity Investments, cutting an estimated $1.48B.
- 1,881 institutional investors held Amgen (AMGN) as of Q1 2019, down from 1,888 in Q4 2018.
- Funds reported $91B of Amgen stock for Q1 2019, down 4.6% quarter-over-quarter.
- 93 funds opened new Amgen positions in Q1 2019 and 112 closed out, a net change of -19 holders.
- The largest Amgen buyer in Q1 2019 was Wells Fargo, an estimated $268M added.
- The largest Amgen seller in Q1 2019 was Fidelity Investments, an estimated $1.48B sold.
Based on aggregated 13F filings for Q1 2019.